Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by Wino115

T.TH

RE:SAC meeting result expected by the end of March

It may take them a bit to compile all the Committees thoughts, questions, etc...

March 26, 2023

T.TH

RE:CQDM

I know this is "research", but there is some significance to this...

March 24, 2023

T.TH

RE:RE:AACR Posters

Wildcard as I said, but the Chinese govt has strategically identified biotech...

March 20, 2023

T.TH

AACR Posters

I'm intrigued to see these once they post them. I know everything around...

March 19, 2023

T.TH

RE:honest peopl

I haven't owned it as long as others here to see all those ups and downs ...

March 17, 2023

T.TH

RE:RE:New Press Release - Theratechnologies to Present Preclinical Data at AACR Demonstrating Synergy Between TH1902 and Anti-PD-L1 Immunotherapy in Cold Tumor Model

Some info on "Cold Tumors",  basically resistant to...

March 14, 2023

T.TH

RE:New Press Release - Theratechnologies to Present Preclinical Data at AACR Demonstrating Synergy Between TH1902 and Anti-PD-L1 Immunotherapy in Cold Tumor Model

It's Alive.... well, sort of. This is pre-clinical again so grain of salt...

March 14, 2023

T.TH

RE:RE:RE:Accountability or lack of it?

Thank you, I stand corrected. I guess there was a "hope" based on...

March 14, 2023

T.TH

RE:Accountability or lack of it?

Good summary. I think they were, as our friend qwerty would say, data-driven...

March 13, 2023

T.TH

RE:SPCEO1 & WINO

I've been pretty consistent along the lines of what SPCEO also said...

March 13, 2023

T.TH

RE:RE:RE:RE:Trying to look at the positives

This was answered in the Q&A section of their call. They said that...

March 8, 2023

T.TH

RE:RE:Trying to look at the positives

At this point, it's pretty simple and we just have to watch it play out...

March 8, 2023

T.TH

RE:RE:RE:Tinfoil Hat

Levesque spoke about the share price on the call, which he normally doesn'...

March 2, 2023

T.TH

RE:RE:RE:HFS and the CC

Important points on EGRIFTA - it is a way more profitable product for bottom...

February 28, 2023

T.TH

One other interesting response

It was interesting in Q&A when in response to an analysts question around...

February 28, 2023

T.TH

RE:RE:Th1902-

Yep. Depends on whether they budgeted something in the $28mil RD line Dubuc...

February 28, 2023

T.TH

RE:RE:Bit of clarity on oncology thoughts from CMO

Lot's of moving parts for them to consider so I'm glad they have...

February 28, 2023

T.TH

RE:RE:Question ???

Dubuc pretty clear the RD number will be around 2021's $28mil and overall...

February 28, 2023

T.TH

Bit of clarity on oncology thoughts from CMO

Last Q was interesting and sort of backs up some here who thought patient...

February 28, 2023

T.TH

RE:Question ???

I'd have to go through the numbers more precisely, but you had $40mil+ of...

February 28, 2023

Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next

Featured Company

NurExone Biologic Inc.

NurExone Biologic Inc. V.NRX

NurExone Biologic Inc. is a biopharmaceutical company. The Company is developing and commercializing an exosome therapy ... view more »